What Researchers Did
The researchers reviewed pre-clinical and clinical evidence for hyperbaric oxygen therapy (HBOT) in ischaemic stroke, including its potential as a neuroprotective preconditioning strategy.
What They Found
They found that HBOT showed significant pre-clinical effectiveness for acute ischaemic stroke, reducing oxidative stress, inflammation, and neural apoptosis, and improving oedema and oxygen perfusion. However, this pre-clinical evidence has largely failed to translate into effective clinical therapy due to inconsistencies in study protocols.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The main limitation highlighted is the significant inconsistency in treatment protocols and design of clinical studies, which has hindered the translation of pre-clinical findings into effective evidence-based therapy.